Your browser doesn't support javascript.
loading
Targeted next generation sequencing identifies clinically actionable mutations in patients with melanoma.
Jeck, William R; Parker, Joel; Carson, Craig C; Shields, Janiel M; Sambade, Maria J; Peters, Eldon C; Burd, Christin E; Thomas, Nancy E; Chiang, Derek Y; Liu, Wenjin; Eberhard, David A; Ollila, David; Grilley-Olson, Juneko; Moschos, Stergios; Neil Hayes, D; Sharpless, Norman E.
Affiliation
  • Jeck WR; Department of Genetics, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
Pigment Cell Melanoma Res ; 27(4): 653-63, 2014 Jul.
Article in En | MEDLINE | ID: mdl-24628946
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: High-Throughput Nucleotide Sequencing / Melanoma / Mutation / Neoplasm Proteins Limits: Female / Humans / Male Language: En Journal: Pigment Cell Melanoma Res Journal subject: NEOPLASIAS Year: 2014 Type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: High-Throughput Nucleotide Sequencing / Melanoma / Mutation / Neoplasm Proteins Limits: Female / Humans / Male Language: En Journal: Pigment Cell Melanoma Res Journal subject: NEOPLASIAS Year: 2014 Type: Article Affiliation country: United States